1-hydroxy-6-(trifluoromethyl)-1h-benzotriazole

We are 1-hydroxy-6-(trifluoromethyl)-1h-benzotriazole CAS:26198-21-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-hydroxy-6-(trifluoromethyl)-1h-benzotriazole
CAS.NO:26198-21-0
Synonyms:6-trifluoromethyl-1-hydroxybenzotriazole
Molecular Formula:C7H4F3N3O
Molecular Weight:203.12100
 
Physical and Chemical Properties:
Density:1.69;
Melting point:143-145oC;
Boiling point:328.6oC;
Flash point:152.5oC;
Index of Refraction:1.595;
 
Specification:
Appearance:White crystal
Purity(HPLC):≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As a condensation reagent
 

1-hydroxy-6-(trifluoromethyl)-1h-benzotriazole


Related News: In addition, due to the complex process of changing the API supplier and the risk of uncertainty, the viscosity of pharmaceutical and specialty API companies is usually better.4-Fluoro-2-methylbenzaldehyde In addition, due to the complex process of changing the API supplier and the risk of uncertainty, the viscosity of pharmaceutical and specialty API companies is usually better.366-99-4 At present, API companies basically use multi-functional and multi-purpose workshops, and the main equipment uses multi-functional reactors to achieve flexible utilization of production capacity.56-41-7 After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply.After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply.

Related Products
Product Name
N,N-dimethyldodecylamine Cas:112-18-5 View Details
6α-ethyl-3α,7α-dihydroxy-24-nor-5β-cholan-23-ol Cas:1612191-86-2 View Details
Isobutyryl chloride View Details
Hafnium hydroxide Cas:12027-05-3 manufacturer BETA-HYDROXYBUTYRATE SODIUM Cas:150-83-4 manufacturer Ruthenium (IV) Oxide Anhydrous Cas:12036-10-1 manufacturer 2-amino-5-fluoro Pyridine Cas:21717-96-4 manufacturer Ansamitocin P-0 Cas:57103-68-1 manufacturer